Literature DB >> 15163753

Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.

Veronika P Pozharskaya1, Laura L Weakland, James C Zimring, Laurie T Krug, Elizabeth R Unger, Andrew Neisch, Harish Joshi, Naoki Inoue, Margaret K Offermann.   

Abstract

Human herpesvirus 8 (HHV-8) encodes multiple proteins that disrupt the host antiviral response, including viral interferon (IFN) regulatory factor 1 (vIRF-1). The product of the vIRF-1 gene blocks responses to IFN when overexpressed by transfection, but the functional consequence of vIRF-1 that is expressed during infection with HHV-8 is not known. These studies demonstrate that BCBL-1 cells that were latently infected with HHV-8 expressed low levels of vIRF-1 that were associated with PML bodies, whereas much higher levels of vIRF-1 were transiently expressed during the lytic phase of HHV-8 replication. The low levels of vIRF-1 that were associated with PML bodies were insufficient to block alpha IFN (IFN-alpha)-induced alterations in gene expression, whereas cells that expressed high levels of vIRF-1 were resistant to some changes induced by IFN-alpha, including the expression of the double-stranded-RNA-activated protein kinase. High levels of vIRF-1 were expressed for only a short period during the lytic cascade, so many cells with HHV-8 in the lytic phase responded to IFN-alpha with increased expression of antiviral genes and enhanced apoptosis. Furthermore, the production of infectious virus was severely compromised when IFN-alpha was present early during the lytic cascade. These studies indicate that the transient expression of high levels of vIRF-1 is inadequate to subvert many of the antiviral effects of IFN-alpha so that IFN-alpha can effectively induce apoptosis and block production of infectious virus when present early in the lytic cascade of HHV-8.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163753      PMCID: PMC416518          DOI: 10.1128/JVI.78.12.6621-6635.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology.

Authors:  P S Moore; Y Chang
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

3.  Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).

Authors:  R Sarid; O Flore; R A Bohenzky; Y Chang; P S Moore
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody.

Authors:  S R Chan; C Bloomer; B Chandran
Journal:  Virology       Date:  1998-01-05       Impact factor: 3.616

5.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.

Authors:  S J Gao; C Boshoff; S Jayachandra; R A Weiss; Y Chang; P S Moore
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

7.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.

Authors:  D H Kedes; M Lagunoff; R Renne; D Ganem
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

8.  Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities.

Authors:  E Cesarman; R G Nador; K Aozasa; G Delsol; J W Said; D M Knowles
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

9.  Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.

Authors:  Naoki Inoue; Jörn Winter; Renu B Lal; Margaret K Offermann; Shin Koyano
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription.

Authors:  J C Zimring; S Goodbourn; M K Offermann
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  23 in total

1.  In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations.

Authors:  Pirouz Daftarian; Raquibul Chowdhury; Philip Ames; Changli Wei; Alan D King; Juan Pablo de Rivero Vaccari; Lloye Dillon; Justin Price; Howard Leung; Brittany Ashlock; Enrique Mesri; Victor Perez; Stephan Züchner; Jochen Reiser; Vance Lemmon; Robert W Keane
Journal:  Hybridoma (Larchmt)       Date:  2011-10

Review 2.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

3.  Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.

Authors:  Sara Chavoshi; Olga Egorova; Ira Kay Lacdao; Sahar Farhadi; Yi Sheng; Vivian Saridakis
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

4.  The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.

Authors:  Carmen M Klass; Laurie T Krug; Veronika P Pozharskaya; Margaret K Offermann
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

Review 5.  Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.

Authors:  Narayanan Sathish; Yan Yuan
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.

Authors:  Thomas Günther; Sabrina Schreiner; Thomas Dobner; Uwe Tessmer; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

Review 8.  Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

Authors:  Kwun Wah Wen; Blossom Damania
Journal:  Cancer Lett       Date:  2009-08-03       Impact factor: 8.679

9.  Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.

Authors:  Chul Hyun Joo; Young C Shin; Michaela Gack; Liguo Wu; David Levy; Jae U Jung
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase.

Authors:  Qiwang Xiang; Hyunwoo Ju; Qian Li; Szu-Chieh Mei; Daming Chen; Young Bong Choi; John Nicholas
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.